Rx Drug Access Partnership
EIN: 571186937 · Henrico, VA · NTEE: E60
| Metric | Value |
|---|---|
| Total Revenue | $1.1M |
| Total Expenses | $803K |
| Net Assets | $1.4M |
Search Intent Cockpit
Rx Drug Access Partnership Form 990, Revenue, CEO Pay, and IRS Filing Signals
Rx Drug Access Partnership is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around Rx Drug Access Partnership in one place.
Form 990 Filing Summary
13 filing years are available, with latest revenue of $845K and expenses of $803K.
Revenue and Expenses
Rx Drug Access Partnership reported $845K in revenue and $803K in expenses, a surplus of $42K.
Executive Compensation
Officer, director, trustee, and key employee pay is reviewed from IRS 990 compensation disclosures when present.
Charity Score and Red Flags
Mission score and red-flag review are shown when AI enrichment is available.
Is Rx Drug Access Partnership Legit?
Insufficient Data
Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →
IRS 990 Data Cockpit
Where the Money Comes From and Where It Goes
Revenue Source Mix
Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.
Expense Deployment
Functional expense detail is not available on the stored filing yet. Existing program percentage and future extracted expense fields will populate this panel.
Across stored filings, Rx Drug Access Partnership shows contribution history pending. Next enrichment targets: revenue-source fields, functional expense detail, IRS BMF classification, AI synthesis.
Decision Cockpit
One-Stop Donor, Research, and Peer Context Hub
| Decision Lens | Signal | What to Inspect Next |
|---|---|---|
| Legitimacy | Insufficient Data | Good filing record; no red flags identified |
| Mission spend | Pending | Unknown |
| Financial durability | Grade A | 13 stored filing years |
| Peer context | Compare with Association Of Small Business Development Centers | Virginia and Health context |
Trust Check
Review legitimacy, deductibility, red flags, and filing consistency.
Open charity check →Peer Benchmark
Compare against real state and category peers.
Compare with Association Of Small Business Development Centers →All Virginia nonprofits
All Health
Local and Sector Spokes
Move into this nonprofit's local market, category, and sector maps.
Henrico, VA nonprofitsHealth in Virginia
Health in Virginia
Follow the Money
Jump into spending, compensation, rankings, and filing-year evidence.
State spending analysisState compensation analysis
Health spending
Best Health charities in Virginia
Relevant rankings
Donation Decision Flow
From Trust Check to Better Alternatives
Verify
Insufficient Data. Check deductibility, filings, and red flags.
2Understand money
Use filing data to inspect spending as enrichment grows.
3Compare
Benchmark against Association Of Small Business Development Centers.
4Decide
Build a shortlist, compare alternatives, and review the latest filing before giving.
Alternative Shopping
Similar Nonprofits Donors Should Compare
The Pharmaceutical Security Institute Inc
Vienna, VA · $1.9M revenue · Score 92/100
Compare side-by-sideAshburn Travel Hockey Inc
Ashburn, VA · $1.1M revenue · Score 92/100
Compare side-by-sideFaithworks Inc
Winchester, VA · $330K revenue · Score 90/100
Compare side-by-sideMetropolitan School Of The Arts
Alexandria, VA · $3.3M revenue · Score 88/100
Compare side-by-sideNext Best Actions
Keep the Investigation Moving
About Rx Drug Access Partnership
Rx Drug Access Partnership (EIN: 571186937) is a nonprofit organization based in Henrico, VA, classified under NTEE code E60. The organization reported total revenue of $1.1M and total assets of $1.6M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Rx Drug Access Partnership's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.
Organization Overview
Rx Drug Access Partnership is a mid-size nonprofit that has been operating for 22 years, with 13 years of IRS 990 filings on record (2012–2024). Revenue has grown at a compound annual rate of 5.7%.
Key Financial Metrics (2024)
From the most recent IRS 990 filing on record:
| Total Revenue | $845K |
| Total Expenses | $803K |
| Surplus / Deficit | +$42K |
| Total Assets | $1.5M |
| Total Liabilities | $102K |
| Net Assets | $1.4M |
| Operating Margin | 4.9% |
| Debt-to-Asset Ratio | 6.8% |
| Months of Reserves | 22.6 months |
Financial Health Grade: A
In 2024, Rx Drug Access Partnership reported a surplus of $42K with revenue exceeding expenses, holds 22.6 months of operating reserves (strong position), has a debt-to-asset ratio of 6.8% (very low leverage).
Financial Trends
Over 13 years of filings (2012–2024), Rx Drug Access Partnership's revenue has grown at a compound annual growth rate (CAGR) of 5.7%.
| Year | Revenue Change | Expense Change | Asset Change |
|---|---|---|---|
| 2024 | +13.3% | +15.6% | +12.6% |
| 2023 | +5.3% | +3.5% | +14.5% |
| 2022 | -2.7% | +9.2% | -4.0% |
| 2021 | +9.3% | +7.2% | +12.7% |
| 2020 | +9.9% | +2.9% | +19.2% |
IRS Tax-Exempt Classification
| IRS Classification Codes | 1000 |
| IRS Ruling Date | 2004 |
Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.
AI Analysis Pending
AI enrichment for Rx Drug Access Partnership has not yet been completed. Basic IRS 990 data is shown below. Check back later for a full transparency report including a Mission Score, spending breakdown, executive compensation analysis, and red flags assessment.
Mission Effectiveness Score
NonprofitSpending's AI analysis rates Rx Drug Access Partnership with a Mission Score of 0 out of 100 (Very Poor). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.
Key Financial Metrics (2024)
From the most recent IRS 990 filing on record:
- The organization reported a surplus of $42K, with revenue exceeding expenses.
- Debt-to-asset ratio: 6.8%.
Frequently Asked Questions about Rx Drug Access Partnership
Is Rx Drug Access Partnership a legitimate charity?
Rx Drug Access Partnership (EIN: 571186937) is a registered tax-exempt nonprofit based in Virginia. It has 13 years of IRS 990 filings on record. Total revenue: $1.1M. No red flags identified. Financial health grade: A.
How does Rx Drug Access Partnership spend its money?
Rx Drug Access Partnership reported $1.1M in total revenue in IRS 990 filings. 13 years of filing data available. Revenue exceeded expenses in the most recent year. Review the full spending breakdown on NonprofitSpending.
Are donations to Rx Drug Access Partnership tax-deductible?
Rx Drug Access Partnership is registered as a tax-exempt nonprofit (EIN: 571186937). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.
Where is Rx Drug Access Partnership located?
Rx Drug Access Partnership is headquartered in Henrico, Virginia and files with the IRS under EIN 571186937. It is classified under NTEE code E60.
How many years of IRS 990 filings does Rx Drug Access Partnership have?
Rx Drug Access Partnership has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $1.1M in total revenue.
Filing History
IRS 990 filing history for Rx Drug Access Partnership showing financial trends over 13 years of public records:
Over 13 years of IRS 990 filings (2012–2024), Rx Drug Access Partnership's revenue has grown by 95.3%, moving from $433K to $845K. Total assets increased by 200.7% over the same period, from $503K to $1.5M. Total functional expenses rose by 125.2%, from $357K to $803K. In its most recent filing year (2024), Rx Drug Access Partnership reported a surplus of $42K, with revenue exceeding expenses. The organization holds $102K in liabilities against $1.5M in assets (debt-to-asset ratio: 6.8%), resulting in net assets of $1.4M.
| Year | Revenue | Expenses | Assets | Liabilities | Officer Comp. % | |
|---|---|---|---|---|---|---|
| 2024 | $845K | $803K | $1.5M | $102K | — | — |
| 2023 | $746K | $695K | $1.3M | $106K | — | — |
| 2022 | $708K | $671K | $1.2M | $49K | — | View 990 |
| 2021 | $728K | $615K | $1.2M | $39K | — | — |
| 2020 | $665K | $574K | $1.1M | $96K | — | View 990 |
| 2019 | $606K | $558K | $909K | $28K | — | View 990 |
| 2018 | $518K | $523K | $856K | $23K | — | View 990 |
| 2017 | $590K | $435K | $866K | $28K | — | View 990 |
| 2016 | $395K | $382K | $707K | $24K | — | View 990 |
| 2015 | $413K | $393K | $685K | $14K | — | View 990 |
| 2014 | $545K | $373K | $662K | $11K | — | View 990 |
| 2013 | $361K | $373K | $493K | $14K | — | View 990 |
| 2012 | $433K | $357K | $503K | $13K | — | View 990 |
Year-by-Year Financial Summary
- 2024: Revenue of $845K, expenses of $803K, and assets of $1.5M (revenue +13.3% year-over-year).
- 2023: Revenue of $746K, expenses of $695K, and assets of $1.3M (revenue +5.3% year-over-year).
- 2022: Revenue of $708K, expenses of $671K, and assets of $1.2M (revenue -2.7% year-over-year).
- 2021: Revenue of $728K, expenses of $615K, and assets of $1.2M (revenue +9.3% year-over-year).
- 2020: Revenue of $665K, expenses of $574K, and assets of $1.1M (revenue +9.9% year-over-year).
- 2019: Revenue of $606K, expenses of $558K, and assets of $909K (revenue +16.8% year-over-year).
- 2018: Revenue of $518K, expenses of $523K, and assets of $856K (revenue -12.1% year-over-year).
- 2017: Revenue of $590K, expenses of $435K, and assets of $866K (revenue +49.5% year-over-year).
- 2016: Revenue of $395K, expenses of $382K, and assets of $707K (revenue -4.4% year-over-year).
- 2015: Revenue of $413K, expenses of $393K, and assets of $685K (revenue -24.3% year-over-year).
- 2014: Revenue of $545K, expenses of $373K, and assets of $662K (revenue +51.0% year-over-year).
- 2013: Revenue of $361K, expenses of $373K, and assets of $493K (revenue -16.5% year-over-year).
- 2012: Revenue of $433K, expenses of $357K, and assets of $503K.
View Individual Filing Years
Explore detailed financial data from each IRS 990 filing year for Rx Drug Access Partnership:
Data Sources and Methodology
This transparency report for Rx Drug Access Partnership is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.
IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.
Disclaimer
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.